The strength of the group is the combination of quite large number of patients with rare lipid disorders in the Lipid Clinic.

This makes it possibel to study the effect of different intervention with advanced laboratory methods at the Department of Nutrition (2,3,4,5,7,8,9) and the existence of clinical patient databases possibel to link to central health registers (1).

  1.  Pregnancy outcomes in familial hypercholesterolemia: a registry-based study. Toleikyte I, Retterstøl K, Leren TP, Iversen PO. Circulation. 2011 Oct 11;124(15):1606-14.
  2. Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy. Skottheim IB, Bogsrud MP, Hermann M, Retterstøl K, Åsberg A. Mol Diagn Ther. 2011 Aug 1;15(4):221-7.
  3. Effect of the fat composition of a single high-fat meal on inflammatory markers in healthy young women. Myhrstad MC, Narverud I, Telle-Hansen VH, Karhu T, Bødtker Lund D, Herzig KH, Makinen M, Halvorsen B, Retterstøl K, Kirkhus B, Granlund L, Holven KB, Ulven SM. Br J Nutr. 2011 Jun 7:1-10.
  4. Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia. Nenseter MS, Lindvig HW, Ueland T, Langslet G, Ose L, Holven KB, Retterstøl K. Atherosclerosis. 2011 Jun;216(2):426-32.
  5. Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe). Solaas K, Legry V, Retterstol K, Berg PR, Holven KB, Ferrières J, Amouyel P, Lien S, Romeo J, Valtueña J, Widhalm K, Ruiz JR, Dallongeville J, Tonstad S, Rootwelt H, Halvorsen B, Nenseter MS, Birkeland KI, Thorsby PM, Meirhaeghe A, Nebb HI. BMC Med Genet. 2010 Oct 12;11:144.
  6. HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study.Bogsrud MP, Ose L, Langslet G, Ottestad I, Strøm EC, Hagve TA, Retterstøl K. Scand Cardiovasc J. 2010 Aug;44(4):197-200.
  7. Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B. Am J Clin Nutr. 2009 Oct;90(4):960-8.
  8. Improved plasma lipids and body weight in overweight/obese patients with type III hyperlipoproteinemia after 4 weeks on a low glycemic diet. Retterstøl K, Hennig CB, Iversen PO. Clin Nutr. 2009 Apr;28(2):213-5.
  9. Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins. Nenseter MS, Ueland T, Retterstøl K, Strøm E, Mørkrid L, Landaas S, Ose L, Aukrust P, Holven KB. Stroke. 2009 Jan;40(1):241-7.
  10. The zero vision for arteriosclerotic cardiovascular disease in younger people. Retterstøl K.Tidsskr Nor Laegeforen. 2008 May 15;128(10):1188-90. 
Published Nov. 21, 2011 11:02 AM